Commercialisation of biotechnology in newly industrialised economies

Shing Chung, Patrick POON, Shantha LIYANAGE

Research output: Journal PublicationsJournal Article (refereed)Researchpeer-review

5 Citations (Scopus)

Abstract

Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas.
Original languageEnglish
Pages (from-to)243-259
Number of pages17
JournalInternational Journal of Biotechnology
Volume6
Issue number2/3
DOIs
Publication statusPublished - 1 Jan 2004

Fingerprint

Biotechnology
Economics
Newly industrialized economies
Commercialization
Industry

Cite this

@article{9dc6d26d8363461aa4930f333b13ff6c,
title = "Commercialisation of biotechnology in newly industrialised economies",
abstract = "Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas.",
author = "POON, {Shing Chung, Patrick} and Shantha LIYANAGE",
year = "2004",
month = "1",
day = "1",
doi = "10.1504/IJBT.2004.004812",
language = "English",
volume = "6",
pages = "243--259",
journal = "International Journal of Biotechnology",
issn = "0963-6048",
publisher = "Inderscience Enterprises Ltd",
number = "2/3",

}

Commercialisation of biotechnology in newly industrialised economies. / POON, Shing Chung, Patrick; LIYANAGE, Shantha.

In: International Journal of Biotechnology, Vol. 6, No. 2/3, 01.01.2004, p. 243-259.

Research output: Journal PublicationsJournal Article (refereed)Researchpeer-review

TY - JOUR

T1 - Commercialisation of biotechnology in newly industrialised economies

AU - POON, Shing Chung, Patrick

AU - LIYANAGE, Shantha

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas.

AB - Biotechnology, the surging wave of economic development in the world, prompted Newly Industrialised Economies (NIEs) in Asia to emulate developed countries in biotechnology development. The stakes are however high and the uncertainty about return on investment has provoked a careful assessment of national scientific and technological strengths. With a focus on Hong Kong, Singapore, and Taiwan, this paper reviews the current market conditions and key factors that may advantage the development of biotechnology industry in the NIEs. It is argued that co-evolution of scientific and technology capabilities are essential, and the NIEs will have to leverage their comparative advantages in technological capabilities and should focus on core competencies in the already locally established biotechnology areas.

UR - http://commons.ln.edu.hk/sw_master/3798

U2 - 10.1504/IJBT.2004.004812

DO - 10.1504/IJBT.2004.004812

M3 - Journal Article (refereed)

VL - 6

SP - 243

EP - 259

JO - International Journal of Biotechnology

JF - International Journal of Biotechnology

SN - 0963-6048

IS - 2/3

ER -